EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii–calcoaceticus complex

Danish Daniyal, Cuiying Mao, Hongyan Shi

Frontiers in Microbiology · 08.07.2026 · 17

DOI: 10.3389/fmicb.2026.1869585 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 08.07.2026. Verfasst von Danish Daniyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun, China. Die Arbeit nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii–calcoaceticus complex (ABC complex) is recognized as one of the most critical multidrug drugs resistant (MDR) pathogens worldwide and remains a major cause of hospital-acquired infections, particularly in intensive care settings. Members of this complex are associated with ventilator-associated pneumonia, bloodstream infections, wound infections, urinary tract infections, and meningitis, often affecting critically ill and immunocompromised patients. Their clinical importance is primarily driven by their remarkable ability to acquire, accumulate, and maintain resistance determinants against multiple classes of antimicrobial agents. The ABC complex acquires resistance through diverse and coordinated mechanisms, including the production of β -lactamases, target-site alterations, efflux pump overexpression, reduced membrane permeability, horizontal gene transfer (HGT), and the mobilization of insertion sequences and other genetic elements that modulate intrinsic and acquired resistance genes. The rapid dissemination of these determinants has significantly limited therapeutic options and contributed to global outbreaks. Accurate identification of individual members within the complex is essential, as closely related species may differ in epidemiology and resistance profiles. A comprehensive understanding of molecular resistance mechanisms, reliable diagnostic approaches, and evolving treatment strategies, including combination therapies and novel agents, is crucial. This review summarizes current knowledge on resistance mechanisms, identification methods, and innovative therapeutic strategies, highlighting the need for integrated clinical and microbiological efforts to combat ABC complex infections.

Schlagwörter

Stichwörter der Autor:innen

Acinetobacter baumannii–calcoaceticus complexantimicrobial resistance mechanismscombination therapyefflux pumpshorizontal gene transfermolecular diagnosticsmultidrug resistanceβ-lactamases

Autor:innen und Institutionen

  • Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun, China.
  • Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China.

Zitieren

APA

Daniyal, D., Mao, C., & Shi, H. (2026). Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii–calcoaceticus complex. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1869585

Vancouver

Daniyal D, Mao C, Shi H. Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii–calcoaceticus complex. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1869585

BibTeX
@article{Daniyal2026,
  author = {Daniyal, Danish and Mao, Cuiying and Shi, Hongyan},
  title = {Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii–calcoaceticus complex},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1869585}
}
Kostenlos starten →